Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Chakos

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 1996
Psychobiologic correlates of treatment response in schizophreniaJ A Lieberman, J M Alvir, A Koreen, et al.
The Journal of Clinical Psychiatry|January 1, 1996
Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophreniaJ A Lieberman, A R Koreen, M Chakos, et al.
Archives of General Psychiatry|February 1, 1994
Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment responseA R Koreen, J Lieberman, J Alvir, et al.
Biological Psychiatry|December 4, 1998
Serotonergic basis of antipsychotic drug effects in schizophreniaJ A Lieberman, R B Mailman, G Duncan, et al.
Journal of Clinical Psychopharmacology|July 31, 2001
Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trialJ P Lindenmayer, J Volavka, J Lieberman, et al.
Biological Psychiatry|January 1, 1995
Clozapine effects on neuroendocrine response to apomorphine challenge testing in chronic neuroleptic nonresponsive schizophrenia: preliminary findingsS Szymanski, J Lieberman, S Pollack, et al.
Schizophrenia Research|December 20, 2000
IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illnessB B Sheitman, M G Murray, J A Snyder, et al.
The American Journal of Psychiatry|December 1, 1995
Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patientsA Chatterjee, M Chakos, A Koreen, et al.
Psychiatric Services (Washington, D.C.)|October 31, 2001
Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophreniaL Citrome, J Volavka, P Czobor, et al.
The American Journal of Psychiatry|May 1, 1995
Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patientsS Szymanski, J A Lieberman, J M Alvir, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 1996
Psychobiologic correlates of treatment response in schizophreniaJ A Lieberman, J M Alvir, A Koreen, et al.
The Journal of Clinical Psychiatry|January 1, 1996
Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophreniaJ A Lieberman, A R Koreen, M Chakos, et al.
Archives of General Psychiatry|February 1, 1994
Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment responseA R Koreen, J Lieberman, J Alvir, et al.
Biological Psychiatry|December 4, 1998
Serotonergic basis of antipsychotic drug effects in schizophreniaJ A Lieberman, R B Mailman, G Duncan, et al.
Journal of Clinical Psychopharmacology|July 31, 2001
Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trialJ P Lindenmayer, J Volavka, J Lieberman, et al.
Biological Psychiatry|January 1, 1995
Clozapine effects on neuroendocrine response to apomorphine challenge testing in chronic neuroleptic nonresponsive schizophrenia: preliminary findingsS Szymanski, J Lieberman, S Pollack, et al.
Schizophrenia Research|December 20, 2000
IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illnessB B Sheitman, M G Murray, J A Snyder, et al.
The American Journal of Psychiatry|December 1, 1995
Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patientsA Chatterjee, M Chakos, A Koreen, et al.
Psychiatric Services (Washington, D.C.)|October 31, 2001
Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophreniaL Citrome, J Volavka, P Czobor, et al.
The American Journal of Psychiatry|May 1, 1995
Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patientsS Szymanski, J A Lieberman, J M Alvir, et al.
Pageof 3